Cardiac and Diabetic Range: Third Party Manufacturing
205 cardiovascular, anti-diabetic, anticoagulant and diuretic products, manufactured as tablets and capsules under your brand at our WHO-GMP plant in Panchkula.
Home›Products›Cardiac and diabetic range
Cardiac medicines are the largest therapy in India, and anti-diabetic medicines grew more than any other large therapy in July 2026. Patients take them every month for life, and the molecules that were under patent until recently are now open to every marketing company. Our catalogue carries 205 products in this range, 110 cardiovascular, 69 anti-diabetic, 12 anticoagulant and antiplatelet and 14 diuretic, all made in the general tablet and capsule sections at Panchkula.
- Why this range. The market figures, the patient base and the patent expiries that make cardiac-diabetic the range marketing companies build first.
- Why this plant for it. 205 products already on the licence, 55 packs manufactured for clients, sustained-release and bilayer tablets, pellet capsules and the laboratory to release them.
- The full catalogue. Every product with composition, form and pack sizes.
14%of India’s medicine market is cardiac therapy, the largest of all (Pharmarack, July 2026)
17.6%value growth of anti-diabetic therapy in July 2026, more than any other large segment
205cardiac and diabetic products on our licence
55packs in this range manufactured for our clients
Cardiac and diabetic packs manufactured for our clients
Each pack carries the client’s brand and our name as manufacturer.
Amlodipine and Atenolol Tablets IP
Atorvastatin and Clopidogrel Capsules
Atorvastatin Tablets IP 10mg
Atorvastatin Tablets IP 20mg
Atorvastatin Tablets IP 40mg
Atorvastatin, Clopidogrel and Aspirin Capsules
Bisoprolol Fumarate and Amlodipine Tablets
Bisoprolol Fumarate and Amlodipine Tablets
Cilnidipine Tablets IP 10mg
Cilnidipine Tablets IP 5mg
Losartan Potassium and Amlodipine Tablets IP
Metoprolol and Amlodipine Tablets
Metoprolol Succinate Prolonged-release Tablets IP 25mg
Metoprolol Succinate Prolonged-release Tablets IP 50mg
Nebivolol Tablets IP 5mg
Rosuvastatin and Aspirin Gastro-resistant Capsules IP
Rosuvastatin and Fenofibrate Tablets IP
Rosuvastatin Tablets IP 10mg
Rosuvastatin Tablets IP 20mg
Rosuvastatin, Clopidogrel and Aspirin Capsules
Telmisartan and Amlodipine Tablets IP
Telmisartan and Chlorthalidone Tablets
Telmisartan and Cilnidipine Tablets
Telmisartan and Hydrochlorothiazide Tablets IP
Telmisartan Tablets IP 40mg
Telmisartan Tablets IP 80mg
Telmisartan, Amlodipine and Hydrochlorothiazide Tablets
Telmisartan, Chlorthalidone and Cilnidipine Tablets
Telmisartan, Chlorthalidone and Cilnidipine Tablets
Dapagliflozin and Metformin Hydrochloride (ER) Tablets
Dapagliflozin and Metformin Hydrochloride (ER) Tablets
Dapagliflozin and Metformin Hydrochloride (ER) Tablets
Dapagliflozin Tablets 10mg
Glimepiride Tablets IP 2mg
Metformin Hydrochloride (SR), Gliclazide (SR) and Pioglitazone Hydrochloride Tablets
Metformin Hydrochloride (SR), Glimepiride and Pioglitazone Tablets
Metformin Hydrochloride (SR), Glimepiride and Pioglitazone Tablets
Metformin Hydrochloride (SR), Glimepiride and Voglibose Tablets
Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP
Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP
Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP
Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP
Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP
Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP
Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP
Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP
Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP
Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP
Metformin Hydrochloride Prolonged-release Tablets IP 500mg
Teneligliptin and Metformin Hydrochloride Prolonged-release Tablets IP
Teneligliptin and Metformin Hydrochloride Prolonged-release Tablets IP
Vildagliptin and Metformin Hydrochloride Tablets IP
Vildagliptin Tablets 50mg
Clopidogrel and Aspirin Capsules
Torsemide Tablets IP 10mgA starter range of 22 products
A first cardiac-diabetic range that covers hypertension, lipids, antiplatelet therapy and type 2 diabetes from first line to add-on, all from the catalogue
| Need | Products |
|---|---|
| Hypertension, single | Telmisartan 40 mg; Amlodipine 5 mg; Metoprolol succinate PR 25 mg and 50 mg |
| Hypertension, combinations | Telmisartan 40 mg + Amlodipine 5 mg; Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg; Telmisartan 40 mg + Chlorthalidone 12.5 mg |
| Lipids | Atorvastatin 10 mg and 20 mg; Rosuvastatin 10 mg and 20 mg |
| Antiplatelet | Clopidogrel 75 mg; Rosuvastatin 10 mg + Clopidogrel 75 mg + Aspirin 75 mg capsules |
| Type 2 diabetes, first line | Metformin PR 500 mg and 1000 mg; Glimepiride 1 mg + Metformin PR 500 mg; Glimepiride 2 mg + Metformin PR 500 mg |
| Type 2 diabetes, add-on | Vildagliptin 50 mg + Metformin 500 mg; Sitagliptin 50 mg + Metformin 500 mg; Dapagliflozin 10 mg; Dapagliflozin 10 mg + Metformin ER 500 mg |
| Diuretic | Torsemide 10 mg |
Send this list, or your own, with pack sizes and annual quantity, and the written proposal comes back product by product.
Why manufacture the range at this plant
What a marketing company gets from Vibcare Healthcare for a cardiac-diabetic range
The molecules are already on the licence
All 205 products in the catalogue, including the empagliflozin, dapagliflozin, sitagliptin, vildagliptin, linagliptin and teneligliptin combinations, are on the plant’s manufacturing licence. There is no wait for a state endorsement before the first batch.
The dosage forms the range needs
Sustained-release and prolonged-release tablets, film-coated bilayer tablets for the SR-plus-immediate combinations, enteric-coated tablets and pellet-filled hard gelatin capsules for the statin and clopidogrel combinations are all made at the plant.
Proof in the packs
55 products in this range have been manufactured for marketing companies under their own brands, with our name as manufacturer on each pack.
A plant certified in 2024
WHO-GMP certified on 24 October 2024 and GMP certified under Revised Schedule M on 14 November 2024, with GLP-certified laboratories. Vendor audits by your quality team are by appointment; Chandigarh airport is 35 km away.
A rate that holds after March 2027
The plant is in Panchkula, Haryana, outside the hill-state budgetary-support scheme that ends on 31 March 2027, so the rate you receive now is the rate after that date.
45 to 60 days, first batch and repeats
Dispatch takes 45 to 60 days from the day the artwork is finalised, for the first batch and for repeat orders, stated in the written proposal.
What a cardiac-diabetic range demands from a plant, and what we do
The technical points of this range and how the plant handles them
Sustained-release metformin
Metformin SR and its combinations with glimepiride, gliclazide, sitagliptin, vildagliptin, dapagliflozin and empagliflozin are the largest group in the range. Each batch is tested for dissolution against the pharmacopoeial profile on Electrolab dissolution testers in the plant’s laboratory before release.
Low-dose glimepiride
Glimepiride at 0.5 mg, 1 mg and 2 mg in combination tablets requires content uniformity across the batch. Uniformity of content is tested on every batch of these combinations and reported on the certificate of analysis.
Moisture-sensitive products
Clopidogrel, rosuvastatin and the gliptins are packed in alu-alu blisters, with the foil printed on the plant’s own rotogravure unit, and other products in PVC or PVDC blisters as the stability data supports.
Coated and prolonged-release tablets
Film-coated, enteric-coated and prolonged-release tablets, including metoprolol succinate PR and the SR combinations, are compressed and coated in the tablet section. See tablet manufacturing for the machines.
Pellet capsules
Atorvastatin, rosuvastatin, clopidogrel and aspirin combinations are filled as pellets in hard gelatin capsules in the capsule section. See capsule manufacturing.
Stability
Stability studies run in Thermolab chambers at the plant, and the data is available to your regulatory team on request.
Ceiling prices
Metformin, glimepiride, atorvastatin, amlodipine, losartan, telmisartan and other molecules in this range are in the National List of Essential Medicines and carry NPPA ceiling prices. We print the MRP you specify; it must stay within the ceiling for those products.
Send your product list and you will receive a written proposal from the plant at Panchkula.
Who manufactures a cardiac-diabetic range with us
Four kinds of buyer, and what each takes from the catalogue
PCD franchise companies
The core hypertension, lipid and type 2 diabetes products in 10×10 and 10×15 packs under their own brand, added to as the franchise network grows.
Generic marketing companies
High-volume molecules under NPPA ceilings, metformin PR, amlodipine, atorvastatin and telmisartan, at batch sizes that hold the rate.
Hospital and institutional suppliers
Tender lists that ask for pharmacopoeial names and strengths, supplied with a certificate of analysis per batch and the document set a tender file needs.
Exporters and importers
BP and USP versions of atorvastatin, rosuvastatin, telmisartan, propranolol, bisoprolol, carvedilol, losartan and metformin are on the licence alongside the IP versions, for markets that register against those pharmacopoeias.
Products in the range
Composition, dosage form and pack sizes for every product in the range.
Download the complete product list (PDF)
Cardiovascular (110 products)
| Product | Form | Pack sizes |
|---|---|---|
| Amlodipine and Atenolol Tablets IPAmlodipine Besylate Eq. to Amlodipine IP 5mg + Atenolol IP 50mg | Tabletuncoated tablet | 10×10 |
| Amlodipine Tablets IP 10mgAmlodipine Besylate Eq. to Amlodipine IP 10mg | Tabletuncoated tablet | |
| Amlodipine Tablets IP 5mgAmlodipine Besylate Eq. to Amlodipine IP 5mg | Tabletuncoated tablet | 10X15, 10×30 |
| Amlodipine Tablets USP 10mgAmlodipine Besylate Eq. to Amlodipine USP 10mg | Tabletuncoated tablet | |
| Amlodipine Tablets USP 5mgAmlodipine Besylate Eq. to Amlodipine USP 5mg | Tabletuncoated tablet | |
| Atorvastatin and Aspirin Capsules IPAtorvastatin Calcium Eq. to Atorvastatin (as pellets) IP 10mg + Aspirin (as pellets) IP 75mg | Capsulehard gelatin capsule | 10×10 |
| Atorvastatin and Clopidogrel CapsulesAtorvastatin Calcium Eq. to Atorvastatin (as pellets) IP 10mg + Clopidogrel Bisulphate Eq. to Clopidogrel (as pellets) IP 75mg | Capsulehard gelatin capsule | 10×10 |
| Atorvastatin and Clopidogrel CapsulesAtorvastatin Calcium Eq. to Atorvastatin (as pellets) IP 20mg + Clopidogrel Bisulphate Eq. to Clopidogrel (as pellets) IP 75mg | Capsulehard gelatin capsule | 10×10 |
| Atorvastatin Calcium, Fenofibrate and Ezetimibe TabletsAtorvastatin Calcium Eq. to Atorvastatin IP 10mg + Fenofibrate IP 160mg + Ezetimibe IP 10mg | Tabletfilm coated tablet | |
| Atorvastatin Tablets BP 10mgAtorvastatin Calcium Eq. to Atorvastatin BP 10mg | Tabletfilm coated tablet | |
| Atorvastatin Tablets BP 20mgAtorvastatin Calcium Eq. to Atorvastatin BP 20mg | Tabletfilm coated tablet | |
| Atorvastatin Tablets IP 10mgAtorvastatin Calcium Eq. to Atorvastatin IP 10mg | Tabletfilm coated tablet | 10×10 |
| Atorvastatin Tablets IP 20mgAtorvastatin Calcium Eq. to Atorvastatin IP 20mg | Tabletfilm coated tablet | 10×10 |
| Atorvastatin Tablets IP 40mgAtorvastatin Calcium Eq. to Atorvastatin IP 40mg | Tabletfilm coated tablet | 10×10 |
| Atorvastatin Tablets IP 80mgAtorvastatin Calcium Eq. to Atorvastatin IP 80mg | Tabletfilm coated tablet | |
| Atorvastatin, Clopidogrel and Aspirin CapsulesAtorvastatin Calcium Eq. to Atorvastatin (as pellets) IP 10mg + Aspirin (as pellets) IP 75mg + Clopidogrel Bisulphate Eq. to Clopidogrel (as pellets) IP 75mg | Capsulehard gelatin capsule | 10×10 |
| Atorvastatin, Clopidogrel and Aspirin CapsulesAtorvastatin Calcium Eq. to Atorvastatin (as pellets) IP 20mg + Aspirin (as pellets) IP 75mg + Clopidogrel Bisulphate Eq. to Clopidogrel (as pellets) IP 75mg | Capsulehard gelatin capsule | 10×10 |
| Azilsartan Medoxomil Tablets 40mgAzilsartan Kamedoxomil Eq. to Azilsartan Medoxomil 40mg | Tabletuncoated tablet | |
| Azilsartan Medoxomil Tablets 80mgAzilsartan Kamedoxomil Eq. to Azilsartan Medoxomil 80mg | Tabletuncoated tablet | |
| Benidipine Hydrochloride and Telmisartan TabletsBenidipine Hydrochloride JP 4mg + Telmisartan IP 40mg | Tablet | |
| Bisoprolol Fumarate and Amlodipine TabletsBisoprolol Fumarate IP 2.5mg + Amlodipine Besylate Eq. to Amlodipine IP 5mg | Tabletfilm coated tablet | |
| Bisoprolol Fumarate and Amlodipine TabletsBisoprolol Fumarate IP 5mg + Amlodipine Besylate Eq. to Amlodipine IP 5mg | Tabletfilm coated tablet | |
| Bisoprolol Fumarate Tablet 2.5mgBisoprolol Fumarate IP 2.5mg | Tabletfilm coated tablet | |
| Bisoprolol Fumarate Tablet 5mgBisoprolol Fumarate IP 5mg | Tabletfilm coated tablet | |
| Bisoprolol Fumarate Tablet USP 2.5mgBisoprolol Fumarate USP 2.5mg | Tabletfilm coated tablet | |
| Bisoprolol Fumarate Tablet USP 5mgBisoprolol Fumarate USP 5mg | Tabletfilm coated tablet | |
| Calcium Dobesilate Capsules 500mgCalcium Dobesilate Monohydrate Eq. to Calcium Dobesilate IP 500mg | Capsulehard gelatin capsule | 10×10 |
| Carvedilol Tablets IP 12.5mgCarvedilol IP 12.5mg | Tabletfilm coated tablet | |
| Carvedilol Tablets IP 3.125mgCarvedilol IP 3.125mg | Tabletfilm coated tablet | 10×10 |
| Carvedilol Tablets IP 6.25mgCarvedilol IP 6.25mg | Tabletfilm coated tablet | 10×10 |
| Carvedilol Tablets USP 3.125mgCarvedilol USP 3.125mg | Tabletfilm coated tablet | |
| Carvedilol Tablets USP 6.25mgCarvedilol USP 6.25mg | Tabletfilm coated tablet | |
| Cilnidipine and Nebivolol Hydrochloride TabletsCilnidipine IP 10mg + Nebivolol Hydrochloride Eq. to Nebivolol IP 5mg | Tabletfilm coated bilayer tablet | |
| Cilnidipine Tablets IP 10mgCilnidipine IP 10mg | Tabletfilm coated tablet | 10X10 |
| Cilnidipine Tablets IP 5mgCilnidipine IP 5mg | Tabletfilm coated tablet | |
| Diltiazem Hydrochloride (SR) Tablets 90mgDiltiazem Hydrochloride (as sustained release form) IP 90mg | Tabletuncoated tablet | |
| Enalapril Maleate Tablets IP 10mgEnalapril Maleate IP 10mg | Tabletuncoated tablet | |
| Enalapril Maleate Tablets IP 2.5mgEnalapril Maleate IP 2.5mg | Tabletuncoated tablet | |
| Enalapril Maleate Tablets IP 5mgEnalapril Maleate IP 5mg | Tabletuncoated tablet | |
| Ezetimibe Tablets IP 10mgEzetimibe IP 10mg | Tabletuncoated tablet | |
| Fenofibrate Tablets IP 145mgFenofibrate IP 145mg | Tabletfilm coated tablet | |
| Ivabradine Tablets 5mgIvabradine Hydrochloride Eq. to Ivabradine 5mg | Tabletfilm coated tablet | |
| Ivabradine Tablets 7.5mgIvabradine Hydrochloride Eq. to Ivabradine 7.5mg | Tabletfilm coated tablet | |
| Labetalol Tablets IP 100mgLabetalol Hydrochloride IP 100mg | Tabletfilm coated tablet | |
| Losartan Potassium and Amlodipine Tablets IPLosartan Potassium IP 50mg + Amlodipine Besylate Eq. to Amlodipine IP 5mg | Tabletfilm coated tablet | |
| Losartan Potassium and Hydrochlorothiazide Tablets IPLosartan Potassium IP 50mg + Hydrochlorothiazide IP 12.5mg | Tabletfilm coated tablet | |
| Losartan Tablets IP 50mgLosartan Potassium IP 50mg | Tabletfilm coated tablet | 10×10 |
| Losartan Tablets USP 50mgLosartan Potassium USP 50mg | Tabletfilm coated tablet | |
| Metoprolol and Amlodipine TabletsMetoprolol Succinate Eq. to Metoprolol Tartarate (As extended release form) IP 50mg + Amlodipine Besylate Eq. to Amlodipine IP 5mg | Tabletfilm coated tablet | 10×10 |
| Metoprolol Succinate (ER) and Cilnidipine TabletsMetoprolol Succinate Eq. to Metoprolol Tartarate (as extended release form) IP 25mg + Cilnidipine IP 10mg | Tabletfilm coated bilayer tablet | |
| Metoprolol Succinate (ER) and Cilnidipine TabletsMetoprolol Succinate Eq. to Metoprolol Tartarate (as extended release form) IP 50mg + Cilnidipine IP 10mg | Tabletfilm coated bilayer tablet | |
| Metoprolol Succinate Prolonged-release Tablets IP 25mgMetoprolol Succinate Eq. to Metoprolol Tartarate (as prolonged release form) IP 25mg | Tabletfilm coated tablet | 10×10 |
| Metoprolol Succinate Prolonged-release Tablets IP 50mgMetoprolol Succinate Eq. to Metoprolol Tartarate (as prolonged release form) IP 50mg | Tabletfilm coated tablet | 10×10 |
| Metoprolol Tartrate (ER), Telmisartan & Chlorthalidone TabletsMetoprolol Succinate Eq. to Metoprolol Tartarate (as extended release form) IP 25mg + Telmisartan IP 40mg + Chlorthalidone IP 12.5mg | Tabletfilm coated bilayer tablet | 10×10 |
| Metoprolol Tartrate (ER), Telmisartan & Chlorthalidone TabletsMetoprolol Succinate Eq. to Metoprolol Tartarate (as extended release form) IP 50mg + Telmisartan IP 40mg + Chlorthalidone IP 12.5mg | Tabletfilm coated bilayer tablet | 10×10 |
| Moxonidine Tablets 0.2mgMoxonidine BP 0.2mg | Tabletfilm coated tablet | |
| Moxonidine Tablets 0.3mgMoxonidine BP 0.3mg | Tabletfilm coated tablet | |
| Moxonidine Tablets 0.4mgMoxonidine BP 0.4mg | Tabletfilm coated tablet | |
| Nebivolol Tablets IP 2.5mgNebivolol Hydrochloride Eq. to Nebivolol IP 2.5mg | Tabletuncoated tablet | 10×10 |
| Nebivolol Tablets IP 5mgNebivolol Hydrochloride Eq. to Nebivolol IP 5mg | Tabletuncoated tablet | 10×10 |
| Nicorandil Tablets IP 10mgNicorandil IP 10mg | Tabletuncoated tablet | |
| Nicorandil Tablets IP 5mgNicorandil IP 5mg | Tabletuncoated tablet | |
| Nifedipine Prolonged-release Tablets IP 10mgNifedipine (as Sustained-release form) IP 10mg | Tabletfilm coated tablet | |
| Nifedipine Prolonged-release Tablets IP 20mgNifedipine (as Sustained-release form) IP 20mg | Tabletfilm coated tablet | 10×10 |
| Nitroglycerin Controlled Release Tablets 2.6mgDiluted Nitroglycerin Eq. to Nitroglycerin (as controlled release form) IP 2.6mg | Tabletuncoated tablet | |
| Nitroglycerin Controlled Release Tablets 6.4mgDiluted Nitroglycerin Eq. to Nitroglycerin (as controlled release form) IP 6.4mg | Tabletuncoated tablet | |
| Olmesartan Medoxomil and Hydrochlorothiazide Tablets IPOlmesartan Medoxomil IP 20mg + Hydrochlorothiazide IP 12.5mg | Tabletfilm coated tablet | |
| Olmesartan Medoxomil and Hydrochlorothiazide Tablets IPOlmesartan Medoxomil IP 40mg + Hydrochlorothiazide IP 12.5mg | Tabletfilm coated tablet | |
| Olmesartan Medoxomil Tablets IP 20mgOlmesartan Medoxomil IP 20mg | Tabletfilm coated tablet | |
| Olmesartan Medoxomil Tablets IP 40mgOlmesartan Medoxomil IP 40mg | Tabletfilm coated tablet | |
| Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide TabletsOlmesartan Medoxomil IP 40mg + Amlodipine Besylate Eq. to Amlodipine IP 5mg + Hydrochlorothiazide IP 12.5mg | Tabletfilm coated tablet | |
| Propranolol Tablets IP 10mgPropranolol Hydrochloride IP 10mg | Tabletuncoated tablet | 10×10 |
| Propranolol Tablets IP 40mgPropranolol Hydrochloride IP 40mg | Tabletuncoated tablet | 10×10 |
| Propranolol Tablets USP/BP 10mgPropranolol Hydrochloride USP/BP 10mg | Tabletuncoated tablet | |
| Propranolol Tablets USP/BP 40mgPropranolol Hydrochloride USP/BP 40mg | Tabletuncoated tablet | |
| Ramipril Tablets IP 1.25mgRamipril IP 1.25mg | Tabletuncoated tablet | |
| Ramipril Tablets IP 2.5mgRamipril IP 2.5mg | Tabletuncoated tablet | |
| Ramipril Tablets IP 5mgRamipril IP 5mg | Tabletuncoated tablet | |
| Ranolazine Extended-release TabletsRanolazine (extended release) 500mg | Tabletfilm coated tablet | |
| Rosuvastatin and Aspirin Gastro-resistant Capsules IPRosuvastatin Calcium Eq. to Rosuvastatin (as granules) IP 10mg + Aspirin (as enteric coated pellets) IP 75mg | Capsulehard gelatin capsule | 10×10 |
| Rosuvastatin and Aspirin Gastro-resistant Capsules IPRosuvastatin Calcium Eq. to Rosuvastatin (as pellets) IP 10mg + Aspirin (as enteric coated pellets) IP 150mg | Capsulehard gelatin capsule | |
| Rosuvastatin and Aspirin Gastro-resistant IP CapsulesRosuvastatin Calcium Eq. to Rosuvastatin (as pellets) IP 20mg + Aspirin (as enteric coated pellets) IP 75mg | Capsulehard gelatin capsule | |
| Rosuvastatin and Clopidogrel CapsulesRosuvastatin Calcium Eq. to Rosuvastatin (as pellets) IP 10mg + Clopidogrel Bisulphate Eq. to Clopidogrel (as pellets) IP 75mg | Capsulehard gelatin capsule | 10×10 |
| Rosuvastatin and Fenofibrate Tablets IPRosuvastatin Calcium Eq. to Rosuvastatin IP 10mg + Fenofibrate IP 145mg | Tabletfilm coated tablet | |
| Rosuvastatin and Fenofibrate Tablets IPRosuvastatin Calcium Eq. to Rosuvastatin IP 10mg + Fenofibrate IP 160mg | Tabletfilm coated tablet | 10×10 |
| Rosuvastatin and Fenofibrate Tablets IPRosuvastatin Calcium Eq. to Rosuvastatin IP 20mg + Fenofibrate IP 160mg | Tabletfilm coated tablet | |
| Rosuvastatin and Fenofibrate Tablets IPRosuvastatin Calcium Eq. to Rosuvastatin IP 5mg + Fenofibrate IP 160mg | Tabletfilm coated tablet | |
| Rosuvastatin Calcium Tablets IP 5mgRosuvastatin Calcium Eq. to Rosuvastatin IP 5mg | Tabletfilm coated tablet | 10×10 |
| Rosuvastatin Tablets BP 10mgRosuvastatin Calcium Eq. to Rosuvastatin BP 10mg | Tabletfilm coated tablet | |
| Rosuvastatin Tablets IP 10mgRosuvastatin Calcium Eq. to Rosuvastatin IP 10mg | Tabletfilm coated tablet | 10×10, 10×15 |
| Rosuvastatin Tablets IP 20mgRosuvastatin Calcium Eq. to Rosuvastatin IP 20mg | Tabletfilm coated tablet | 10×10 |
| Rosuvastatin Tablets IP 40mgRosuvastatin Calcium Eq. to Rosuvastatin IP 40mg | Tabletfilm coated tablet | 10×10 |
| Rosuvastatin, Clopidogrel and Aspirin CapsulesRosuvastatin Calcium Eq. to Rosuvastatin (as pellets) IP 10mg + Aspirin (as pellets) IP 75mg + Clopidogrel Bisulphate Eq. to Clopidogrel (as pellets) IP 75mg | Capsulehard gelatin capsule | 10×10 |
| Rosuvastatin, Clopidogrel and Aspirin CapsulesRosuvastatin Calcium Eq. to Rosuvastatin (as pellets) IP 20mg + Aspirin (as enteric coated pellets) IP 75mg + Clopidogrel Bisulphate Eq. to Clopidogrel (as pellets) IP 75mg | Capsulehard gelatin capsule | 10×10 |
| Sacubitril and Valsartan TabletsSacubitril Valsartan Sodium Eq. to Sacubitril 24mg & Valsartan IP 26mg 50mg | Tabletfilm coated tablet | 10×10 |
| Sacubitril and Valsartan TabletsSacubitril Valsartan Sodium Eq. to Sacubitril 49mg & Valsartan IP 51mg 100mg | Tabletfilm coated tablet | |
| Sacubitril and Valsartan TabletsSacubitril Valsartan Sodium Eq. to Sacubitril 97mg & Valsartan IP 103mg 200mg | Tabletfilm coated tablet | |
| Telmisartan and Amlodipine Tablets IPTelmisartan IP 40mg + Amlodipine Besylate Eq. to Amlodipine IP 5mg | Tabletuncoated tablet | 10×10, 10×15 |
| Telmisartan and Chlorthalidone TabletsTelmisartan IP 40mg + Chlorthalidone IP 12.5mg | Tabletuncoated bilayer tablet | 10×15, 10×10 |
| Telmisartan and Cilnidipine TabletsTelmisartan IP 40mg + Cilnidipine IP 10mg | Tabletfilm coated tablet | 10×10 |
| Telmisartan and Hydrochlorothiazide Tablets IPTelmisartan IP 40mg + Hydrochlorothiazide IP 12.5mg | Tabletuncoated bilayer tablet | 10X15, 10×10 |
| Telmisartan and Hydrochlorothiazide Tablets IPTelmisartan IP 80mg + Hydrochlorothiazide IP 12.5mg | Tabletuncoated bilayer tablet | |
| Telmisartan and Nebivolol Hydrochloride TabletsTelmisartan IP 40mg + Nebivolol Hydrochloride Eq. to Nebivolol IP 5mg | Tabletuncoated bilayer tablet | |
| Telmisartan Tablets BP 20mgTelmisartan BP 20mg | Tabletuncoated tablet | |
| Telmisartan Tablets IP 20mgTelmisartan IP 20mg | Tabletuncoated tablet | |
| Telmisartan Tablets IP 40mgTelmisartan IP 40mg | Tabletuncoated tablet | 10×10 |
| Telmisartan Tablets IP 80mgTelmisartan IP 80mg | Tabletuncoated tablet | |
| Telmisartan, Amlodipine and Hydrochlorothiazide TabletsTelmisartan IP 40mg + Amlodipine Besylate Eq. to Amlodipine IP 5mg + Hydrochlorothiazide IP 12.5mg | Tabletuncoated bilayer tablet | 10×10 |
| Telmisartan, Chlorthalidone and Cilnidipine TabletsTelmisartan IP 40mg + Chlorthalidone IP 12.5mg + Cilnidipine IP 10mg | Tabletfilm coated tablet | 10×10, 10×15 |
| Telmisartan, Chlorthalidone and Cilnidipine TabletsTelmisartan IP 40mg + Chlorthalidone IP 6.25mg + Cilnidipine IP 10mg | Tabletfilm coated tablet |
Anti-diabetic (69 products)
| Product | Form | Pack sizes |
|---|---|---|
| Acarbose and Metformin Hydrochloride TabletsAcarbose IP 25mg + Metformin Hydrochloride IP 500mg | Tabletfilm coated tablet | |
| Acarbose and Metformin Hydrochloride TabletsAcarbose IP 50mg + Metformin Hydrochloride IP 500mg | Tabletfilm coated tablet | |
| Acarbose Tablets IP 100mgAcarbose IP 100mg | Tabletuncoated tablet | |
| Acarbose Tablets IP 50mgAcarbose IP 50mg | Tabletuncoated tablet | |
| Canagliflozin Tablets 100mgCanagliflozin Hemihydrate Eq. to Canagliflozin 100mg | Tabletfilm coated tablet | |
| Dapagliflozin and Metformin Hydrochloride (ER) TabletsDapagliflozin Propanediol Monohydrate Eq. to Dapagliflozin 10mg + Metformin Hydrochloride (as extended release form) IP 1000mg | Tabletfilm coated tablet | 10×10 |
| Dapagliflozin and Metformin Hydrochloride (ER) TabletsDapagliflozin Propanediol Monohydrate Eq. to Dapagliflozin 10mg + Metformin Hydrochloride (as extended release form) IP 500mg | Tabletfilm coated tablet | 10X10 |
| Dapagliflozin and Metformin Hydrochloride (ER) TabletsDapagliflozin Propanediol Monohydrate Eq. to Dapagliflozin 5mg + Metformin Hydrochloride (as extended release form) IP 1000mg | Tabletfilm coated tablet | |
| Dapagliflozin and Metformin Hydrochloride (ER) TabletsDapagliflozin Propanediol Monohydrate Eq. to Dapagliflozin 5mg + Metformin Hydrochloride (as extended release form) IP 500mg | Tabletfilm coated tablet | |
| Dapagliflozin Tablets 10mgDapagliflozin Propanediol Monohydrate Eq. to Dapagliflozin 10mg | Tabletfilm coated tablet | 10X15, 10X10 |
| Dapagliflozin Tablets 5mgDapagliflozin Propanediol Monohydrate Eq. to Dapagliflozin 5mg | Tabletfilm coated tablet | 10×10 |
| Empagliflozin & Linagliptin TabletsEmpagliflozin 10mg + Linagliptin 5mg | Tabletfilm coated tablet | |
| Empagliflozin & Linagliptin TabletsEmpagliflozin 25mg + Linagliptin 5mg | Tabletfilm coated tablet | |
| Empagliflozin & Metformin Hydrochloride TabletsEmpagliflozin 12.5mg + Metformin Hydrochloride IP 1000mg | Tabletfilm coated tablet | |
| Empagliflozin & Metformin Hydrochloride TabletsEmpagliflozin 12.5mg + Metformin Hydrochloride IP 500mg | Tabletfilm coated tablet | |
| Empagliflozin & Metformin Hydrochloride TabletsEmpagliflozin 5mg + Metformin Hydrochloride IP 1000mg | Tabletfilm coated tablet | |
| Empagliflozin & Metformin Hydrochloride TabletsEmpagliflozin 5mg + Metformin Hydrochloride IP 500mg | Tabletfilm coated tablet | |
| Empagliflozin TabletsEmpagliflozin 10mg | Tabletfilm coated tablet | |
| Empagliflozin TabletsEmpagliflozin 25mg | Tabletfilm coated tablet | |
| Gliclazide and Metformin Hydrochloride TabletsGliclazide IP 80mg + Metformin Hydrochloride IP 500mg | Tabletuncoated tablet | 10×10 |
| Gliclazide Extended-Release Tablets IP 60mgGliclazide (as extended release form) IP 60mg | Tabletuncoated tablet | |
| Glimepiride Tablets IP 1mgGlimepiride IP 1mg | Tabletuncoated tablet | 10×10 |
| Glimepiride Tablets IP 2mgGlimepiride IP 2mg | Tabletuncoated tablet | 10X10 |
| Linagliptin Tablets 5mgLinagliptin 5mg | Tabletfilm coated tablet | 10×10 |
| Metformin Hydrochloride (ER) and Gliclazide (MR) TabletsMetformin Hydrochloride (as extended release form) IP 500mg + Gliclazide (as modified release form) IP 60mg | Tabletuncoated bilayer tablet | |
| Metformin Hydrochloride (SR) and Glibenclamide TabletsMetformin Hydrochloride (as sustained release form) IP 500mg + Glibenclamide IP 5mg | Tabletuncoated bilayer tablet | |
| Metformin Hydrochloride (SR), Gliclazide (SR) and Pioglitazone Hydrochloride TabletsGliclazide (as sustained release form) IP 30mg + Pioglitazone Hydrochloride Eq. to Pioglitazone IP 15mg + Metformin Hydrochloride (In sustained release form) IP 500mg | Tabletuncoated bilayer tablet | |
| Metformin Hydrochloride (SR), Gliclazide (SR) and Pioglitazone Hydrochloride TabletsGliclazide (as sustained release form) IP 60mg + Pioglitazone Hydrochloride Eq. to Pioglitazone IP 15mg + Metformin Hydrochloride (as sustained release form) IP 500mg | Tabletuncoated bilayer tablet | |
| Metformin Hydrochloride (SR), Glimepiride and Pioglitazone TabletsMetformin Hydrochloride (as sustained release form) IP 500mg + Glimepiride IP 1mg + Pioglitazone Hydrochloride Eq. to Pioglitazone IP 15mg | Tabletuncoated bilayer tablet | 10×15 |
| Metformin Hydrochloride (SR), Glimepiride and Pioglitazone TabletsMetformin Hydrochloride (as sustained release form) IP 500mg + Glimepiride IP 2mg + Pioglitazone Hydrochloride Eq. to Pioglitazone IP 15mg | Tabletuncoated bilayer tablet | 10×15 |
| Metformin Hydrochloride (SR), Glimepiride and Voglibose TabletsMetformin Hydrochloride (as sustained release form) IP 500mg + Glimepiride IP 1mg + Voglibose IP 0.2mg | Tabletuncoated bilayer tablet | 10×15 |
| Metformin Hydrochloride and Linagliptin TabletsMetformin Hydrochloride IP 1000mg + Linagliptin 2.5mg | Tabletfilm coated tablet | |
| Metformin Hydrochloride and Linagliptin TabletsMetformin Hydrochloride IP 500mg + Linagliptin 2.5mg | Tabletfilm coated tablet | |
| Metformin Hydrochloride and Linagliptin TabletsMetformin Hydrochloride IP 850mg + Linagliptin 2.5mg | Tabletfilm coated tablet | |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IPMetformin Hydrochloride (as prolonged release form) IP 1000mg + Glimepiride IP 1mg | Tabletuncoated bilayer tablet | 10×15 |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IPMetformin Hydrochloride (as prolonged release form) IP 1000mg + Glimepiride IP 2mg | Tabletuncoated bilayer tablet | 10X10, 10×15 |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IPMetformin Hydrochloride (as prolonged release form) IP 1000mg + Glimepiride IP 3mg | Tabletuncoated bilayer tablet | 10×10, 10×15 |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IPMetformin Hydrochloride (as prolonged release form) IP 1000mg + Glimepiride IP 4mg | Tabletuncoated bilayer tablet | 10×10, 10×15 |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IPMetformin Hydrochloride (as prolonged release form) IP 500mg + Glimepiride IP 0.5mg | Tabletuncoated bilayer tablet | 10×15, 10×10 |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IPMetformin Hydrochloride (as prolonged release form) IP 500mg + Glimepiride IP 1mg | Tabletuncoated bilayer tablet | 10×10, 10×15 |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IPMetformin Hydrochloride (as prolonged release form) IP 500mg + Glimepiride IP 2mg | Tabletuncoated bilayer tablet | 10×10, 10×15 |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IPMetformin Hydrochloride (as prolonged release form) IP 500mg + Glimepiride IP 3mg | Tabletuncoated bilayer tablet | 10×15, 10×10 |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IPMetformin Hydrochloride (as prolonged release form) IP 500mg + Glimepiride IP 4mg | Tabletuncoated bilayer tablet | 10×10, 10×15 |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IPMetformin Hydrochloride (as prolonged release form) IP 850mg + Glimepiride IP 1mg | Tabletuncoated bilayer tablet | |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IPMetformin Hydrochloride (as prolonged release form) IP 850mg + Glimepiride IP 2mg | Tabletuncoated bilayer tablet | |
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IPMetformin Hydrochloride (as prolonged release form) IP 850mg + Glimepiride IP 3mg | Tabletuncoated bilayer tablet | |
| Metformin Hydrochloride Prolonged-release Tablets BP 1000mgMetformin Hydrochloride (as prolonged release form) BP 1000mg | Tabletuncoated tablet | |
| Metformin Hydrochloride Prolonged-release Tablets IP 1000mgMetformin Hydrochloride (as prolonged release form) IP 1000mg | Tabletuncoated tablet | 10×10 |
| Metformin Hydrochloride Prolonged-release Tablets IP 500mgMetformin Hydrochloride (as prolonged release form) IP 500mg | Tabletuncoated tablet | 10×10 |
| Pioglitazone Tablets IP 15mgPioglitazone Hydrochloride Eq. to Pioglitazone IP 15mg | Tabletuncoated tablet | |
| Pioglitazone Tablets IP 30mgPioglitazone Hydrochloride Eq. to Pioglitazone IP 30mg | Tabletuncoated tablet | |
| Repaglinide Tablets IP 0.5mgRepaglinide IP 0.5mg | Tabletuncoated tablet | 10×10 |
| Repaglinide Tablets IP 1mgRepaglinide IP 1mg | Tabletuncoated tablet | |
| Repaglinide Tablets IP 2mgRepaglinide IP 2mg | Tabletuncoated tablet | |
| Sitagliptin and Metformin Hydrochloride (SR) TabletsSitagliptin Phosphate Monohydrate Eq. to Sitagliptin IP 50mg + Metformin Hydrochloride (as sustained release form) IP 1000mg | Tabletfilm coated tablet | |
| Sitagliptin Phosphate & Metformin Hydrochloride TabletsMetformin Hydrochloride IP 500mg + Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin IP 50mg | Tabletfilm coated tablet | |
| Sitagliptin Tablets IP 100mgSitagliptin Phosphate Monohydrate Eq. to Sitagliptin IP 100mg | Tabletfilm coated tablet | 10×10 |
| Sitagliptin Tablets IP 25mgSitagliptin Phosphate Monohydrate Eq. to Sitagliptin IP 25mg | Tabletfilm coated tablet | |
| Sitagliptin Tablets IP 50mgSitagliptin Phosphate Monohydrate Eq. to Sitagliptin IP 50mg | Tabletfilm coated tablet | 10×10 |
| Teneligliptin and Metformin Hydrochloride Prolonged-release Tablets IPTeneligliptin Hydrobromide Hydrate Eq. to Teneligliptin IP 20mg + Metformin Hydrochloride (in sustained release form) IP 1000mg | Tabletuncoated bilayer tablet | |
| Teneligliptin and Metformin Hydrochloride Prolonged-release Tablets IPTeneligliptin Hydrobromide Hydrate Eq. to Teneligliptin IP 20mg + Metformin Hydrochloride (in sustained release form) IP 500mg | Tabletuncoated bilayer tablet | 10×10, 20x1x10 |
| Teneligliptin Tablets IP 20mgTeneligliptin Hydrobromide Hydrate Eq. to Teneligliptin IP 20mg | Tabletfilm coated tablet | 10×10 |
| Vildagliptin and Metformin Hydrochloride Tablets IPVildagliptin IP 50mg + Metformin Hydrochloride IP 1000mg | Tabletfilm coated tablet | 10×10, 10×15 |
| Vildagliptin and Metformin Hydrochloride Tablets IPVildagliptin IP 50mg + Metformin Hydrochloride IP 500mg | Tabletfilm coated tablet | 10×15, 10x1x10 |
| Vildagliptin and Metformin Hydrochloride Tablets IPVildagliptin IP 50mg + Metformin Hydrochloride IP 850mg | Tabletfilm coated tablet | 10×10 |
| Vildagliptin Sustained Release Tablets IP 100mgVildagliptin (as sustained release form) IP 100mg | Tabletuncoated tablet | |
| Vildagliptin Tablets 50mgVildagliptin IP 50mg | Tabletuncoated tablet | 10x1x10, 10×10, 10X15 |
| Voglibose Tablets IP 0.2mgVoglibose IP 0.2mg | Tabletuncoated tablet | |
| Voglibose Tablets IP 0.3mgVoglibose IP 0.3mg | Tabletuncoated tablet |
Anticoagulants and antiplatelets (12 products)
| Product | Form | Pack sizes |
|---|---|---|
| Clopidogrel and Aspirin CapsulesClopidogrel Bisulphate Eq. to Clopidogrel (as pellets) IP 75mg + Aspirin (as pellets) IP 75mg | Capsulehard gelatin capsule | |
| Clopidogrel and Aspirin CapsulesClopidogrel Bisulphate Eq. to Clopidogrel IP 75mg + Aspirin IP 75mg | Capsulehard gelatin capsule | 10×10 |
| Clopidogrel and Aspirin Tablets IPClopidogrel Bisulphate Eq. to Clopidogrel IP 150mg + Aspirin IP 75mg | Tabletfilm coated tablet | |
| Clopidogrel Tablets IP 75mgClopidogrel Bisulphate Eq. to Clopidogrel IP 75mg | Tabletfilm coated tablet | |
| Dabigatran Etexilate Capsules 110mgDabigatran Etexilate Mesilate Eq. to Dabigatran Etexilate 110mg | Capsulehard gelatin capsule | |
| Dabigatran Etexilate Capsules 150mgDabigatran Etexilate Mesilate Eq. to Dabigatran Etexilate 150mg | Capsulehard gelatin capsule | |
| Prasugrel Tablets IP 10mgPrasugrel Hydrochloride Eq. to Prasugrel IP 10mg | Tabletfilm coated tablet | |
| Rivaroxaban Tablets 10mgRivaroxaban 10mg | Tabletfilm coated tablet | |
| Rivaroxaban Tablets 15mgRivaroxaban 15mg | Tabletfilm coated tablet | |
| Rivaroxaban Tablets 2.5mgRivaroxaban 2.5mg | Tabletfilm coated tablet | |
| Rivaroxaban Tablets 20mgRivaroxaban 20mg | Tabletfilm coated tablet | |
| Ticagrelor Tablets IP 90mgTicagrelor IP 90mg | Tabletfilm coated tablet |
Diuretics (14 products)
| Product | Form | Pack sizes |
|---|---|---|
| Acetazolamide Tablets IP 250mgAcetazolamide IP 250mg | Tabletuncoated tablet | |
| Chlorthalidone Tablets IP 12.5mgChlorthalidone IP 12.5mg | Tabletuncoated tablet | |
| Chlorthalidone Tablets IP 6.25mgChlorthalidone IP 6.25mg | Tabletuncoated tablet | |
| Eplerenone Tablets IP 25mgEplerenone IP 25mg | Tabletfilm coated tablet | |
| Frusemide and Spironolactone TabletsFrusemide IP 20mg + Spironolactone IP 50mg | Tabletfilm coated tablet | |
| Frusemide Tablets IP 40mgFrusemide IP 40mg | Tabletuncoated tablet | |
| Tolvaptan Tablets 15mgTolvaptan IP 15mg | Tabletuncoated tablet | |
| Tolvaptan Tablets 30mgTolvaptan IP 30mg | Tabletuncoated tablet | |
| Torsemide and Spironolactone TabletsTorsemide IP 10mg + Spironolactone IP 50mg | Tabletuncoated tablet | |
| Torsemide and Spironolactone TabletsTorsemide IP 20mg + Spironolactone IP 50mg | Tabletuncoated tablet | |
| Torsemide and Spironolactone TabletsTorsemide IP 5mg + Spironolactone IP 50mg | Tabletuncoated tablet | |
| Torsemide Tablets IP 10mgTorsemide IP 10mg | Tabletuncoated tablet | |
| Torsemide Tablets IP 20mgTorsemide IP 20mg | Tabletuncoated tablet | |
| Torsemide Tablets IP 5mgTorsemide IP 5mg | Tabletuncoated tablet |
Rate, batch, lead time and documents
The terms every proposal states
Rate
The rate is quoted in writing, product by product, against your pack sizes and annual quantity. The plant is outside the hill-state budgetary-support scheme, so the rate you receive now is the rate after March 2027.
Minimum quantity
One batch per product. The batch size for each product is stated in the proposal.
Lead time
Dispatch takes 45 to 60 days from the day the artwork is finalised, for the first batch and for repeat orders.
Payment
An advance on the first order, and terms as mutually agreed after that.
Dispatch
To your depots in any state by road, with freight to your account.
Documents
A certificate of analysis with every batch, copies of the licences and certificates, the Site Master File for vendor qualification, stability data on request, and a quality agreement after order confirmation.
Compliance notes for this range
Prices, combinations and labelling
Fixed-dose combinations
Combinations are manufactured only where the combination is approved. Combinations banned by the Ministry of Health are not manufactured.
Labelling
Products in this range are Schedule H medicines and are labelled accordingly, with the generic name in the prominence required by Rule 96 and the manufacturer’s name, licence number and batch details on every pack.
Release
Every batch is tested in the GLP-certified laboratory and released with a certificate of analysis that travels with the consignment.
Why cardiac and diabetic is the range to build
The market, the patients and the molecules, with sources
The largest therapy, still growing at double digits
Cardiac therapies account for 14 per cent of the Indian pharmaceutical market, the largest single segment, and grew 14.7 per cent in value in July 2026. Anti-diabetic therapies grew 17.6 per cent in the same month, more than any other large segment, against 12.1 per cent for the market as a whole and 10.2 per cent on a moving annual basis. Source: Pharmarack Technologies, reported in BioSpectrum, 9 August 2026.
A patient base that keeps growing
The ICMR-INDIAB study of 113,043 adults across India found diabetes in 11.4 per cent, prediabetes in 15.3 per cent, hypertension in 35.5 per cent and dyslipidaemia in 81.2 per cent of those tested, higher than every earlier estimate. Source: ICMR-INDIAB-17, The Lancet Diabetes and Endocrinology, July 2023.
Chronic therapy means repeat sales
A patient started on metformin, telmisartan or atorvastatin buys the same brand every month for years. A cardiac-diabetic range gives a marketing company repeat prescriptions from the same doctors and chemists rather than one-time acute sales, which is why it is the range most companies build first.
Patent expiries have opened the premium molecules
Sitagliptin went off patent in India in 2022 and empagliflozin on 11 March 2025; generic brands launched within days at about 80 per cent below the innovator price, and dozens of brands followed within weeks. Dapagliflozin, vildagliptin, linagliptin and teneligliptin are likewise open. A marketing company can now offer the gliptin and gliflozin combinations that were reserved for multinational brands until recently. Source: BioSpectrum, 11 April 2025.
Combinations carry the margin
The basic molecules such as metformin, amlodipine and atorvastatin are under NPPA ceiling prices and sell on volume. The combinations, sustained-release forms and newer molecules sit outside the ceiling and carry the margin. A range needs both, and a plant that makes both.
Factory tour video
Seven minutes inside the WHO-GMP plant at Dabkori, Panchkula, covering the manufacturing sections, packing lines and laboratories.
Questions marketing companies ask
Answered from the plant
Which cardiac and diabetic products can you manufacture under our brand?
All 205 products in the catalogue. If you need a composition that is not on the list, send it with the strength and pack; a product not yet on the licence needs the state authority’s endorsement before the first batch, which adds a few weeks.
Can you make sustained-release metformin combinations?
Yes. Glimepiride with metformin SR, gliclazide ER with metformin ER, sitagliptin, vildagliptin, dapagliflozin and empagliflozin combinations with metformin are on the list and are made in the tablet section.
What is the minimum quantity for a cardiac-diabetic range?
One batch per product. The batch size depends on the product and pack, and the written proposal states it against each product you ask for.
How is the rate quoted for a range of 20 or 30 products?
In writing, product by product, against your pack sizes and annual quantity. Send the whole list at once; the proposal covers rate per pack, batch size, pack format, capacity committed, payment terms, lead time and documents.
What is the lead time for the first supply of a range?
45 to 60 days from the day the artwork is finalised for each product, for the first batch and for repeat orders.
Can you match the formulation of a brand we already sell?
Send the reference product and its pack. For a product already on our licence the first batch follows the standard 45 to 60 day timeline; where the release profile or excipients differ from ours, the formulation team assesses the change before quoting, and any product not yet on the licence needs the state endorsement first.
Do you supply the documents our regulatory team needs?
Yes. Copies of the manufacturing licence and WHO-GMP certificate, the Site Master File, a certificate of analysis with every batch, and stability data on request. A quality agreement is signed after order confirmation.
Send your product list today
Send us your products and strengths, pack sizes, annual quantity and artwork status. You will receive a written proposal covering rate, batch size, pack format, capacity, payment terms, lead time and documents.
info.vh@vibcare.co.in · +91 85660 76607 · Khasra 6/2/2, Kot Road, Village Dabkori, Panchkula, Haryana 134103 · Download brochure
